Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
Exelixis
Toni K Choueiri; Thomas Powles; Laurence Albiges; Mauricio Burotto; Cezary Szczylik; Bogdan Zurawski; Eduardo Yanez Ruiz; Marco Maruzzo; Alberto Suarez Zaizar; Luis E Fein; Fabio A Schutz; Daniel Y C Heng; Fong Wang; Fabio Mataveli; Yu-Lin Chang; Maximiliano van Kooten Losio; Cristina Suarez; Robert J Motzer; COSMIC-313 Investigators